Results 1 to 10 of about 32,253 (267)
Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction. [PDF]
PLoS ONE, 2016 Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics.
Kasper Rossing +10 more
doaj +6 more sources
Cells, 2020 Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—
Ilona Cuijpers +2 more
exaly +3 more sources
Changes of calcium cycling in HFrEF and HFpEF
Mechanobiology in Medicine, 2023 Dysfunctions of calcium cycling occur in heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF). HFrEF and HFpEF showed Ca2+ leakage at diastole. The compensation of Na+/Ca2+ exchanger and the decrease of T-tubule density reduces cytoplasmic Ca2+ concentration in HFrEF and impairs systolic function.
Shou, Jian, Huo, Yunlong
exaly +3 more sources
Epicardial fat remodeling in end-stage heart failure with reduced ejection fraction [PDF]
Cardiovascular DiabetologyBackground Epicardial adipose tissue (EAT) transformation in heart failure with reduced ejection fraction (HFrEF) is poorly understood, which limits its potential as a therapeutic target and prognostic factor. The aim of our study was to characterize EAT
Maciej Mączewski +17 more
doaj +2 more sources
Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]
, 2017 OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M +16 more
core +20 more sources
Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation [PDF]
Reviews in Cardiovascular Medicine, 2021 Heart failure (HF) is a complex clinical syndrome characterised by significant morbidity and mortality worldwide. Evidence-based therapies for the management of HF include several well-established neurohormonal antagonists and antiarrhythmic drug ...
Catrin Sohrabi +6 more
doaj +1 more source
Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training [PDF]
Reviews in Cardiovascular Medicine, 2022 Heart failure with reduced ejection fraction is associated with increased exercise intolerance, morbidity, and mortality. Importantly, exercise intolerance in heart failure with reduced ejection fraction is a key factor limiting patient quality of ...
Natasha G. Boyes +3 more
doaj +1 more source
Global Heart, 2023 Background: The rates of guideline-directed medical therapy (GDMT) prescription for heart failure with reduced ejection fraction (HFrEF) in Asia remain sub-optimal.
Aishwarya Vijay +11 more
doaj +1 more source
Medical Journal of Babylon, 2022 Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman +1 more
doaj +1 more source